IQV
SHORTINSIDER SELLIQVIA HLDGS INC
Research: Finviz ↗·Perplexity ↗
🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.
News Summary
PositiveIQVIA delivered strong organic growth with Q1-Q2 2026 revenue up 8.4-8.7% YoY, beat EPS consensus in Q2, and raised full-year 2026 guidance across revenue, EBITDA, and EPS metrics. The company successfully executed strategic acquisitions (Charles River drug discovery assets), deployed AI-native operations (192 agents across 64 use cases), and strengthened its balance sheet via euro debt refinancing, while generating robust free cash flow growth and maintaining aggressive share repurchases ($950M in H1 2026).
Funds Reducing / Exiting (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Viking Global | Andreas Halvorsen | 0 | −619K | — | 0.4% | -100% | EXITED |
| Appaloosa LP | David Tepper | 0 | −280K | — | 0.9% | -100% | EXITED |
| Glenview Capital | Larry Robbins | 0 | −200K | — | 1.0% | -100% | EXITED |
Shares Held reflects quarter-end positions for partial reductions. Funds that fully exited show 0 shares held. ∆ Shares is the change from the prior quarter. % of Fund is the prior-quarter position size — how much of the book was sold down.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed | Src |
|---|---|---|---|---|---|---|---|
| STAUB W RICHARD | See Remarks | SELL | 6K | $232.68 | $1.28M | 2026-08-03 | ↗ |
| Patel Bhavik | See Remarks | SELL | 2K | $235.27 | $0.44M | 2026-07-31 | ↗ |
| Sherbet Eric | See Remarks | SELL | 5K | $249.16 | $1.25M | 2026-07-29 | ↗ |
| Cherofsky Keriann | See Remarks | SELL | 558 | $245.21 | $0.14M | 2026-07-29 | ↗ |
| BOUSBIB ARI | See Remarks | SELL | 4K | $247.10 | $1.10M | 2026-07-29 | ↗ |
| BOUSBIB ARI | See Remarks | SELL | 5K | $246.85 | $1.13M | 2026-07-29 | ↗ |
| BOUSBIB ARI | See Remarks | SELL | 44K | $246.08 | $10.84M | 2026-07-29 | ↗ |
| BOUSBIB ARI | See Remarks | SELL | 53K | $244.78 | $13.02M | 2026-07-29 | ↗ |